Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
QuantumCor Sees Future of Heart Failure Treatment in No Device Left Behind
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
Medical Device Startups Getting Squeezed by Recession, Lawmakers, Says E&Y Report
|
Luke Timmerman |
10/13/09 |
National
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Boston Scientific Pays $716M to Settle Patent Dispute with J&J
|
Luke Timmerman |
09/29/09 |
Boston
|
|
MooBella’s Revamped Ice Cream Machines Debut at MIT After $18M Financing Deal
|
Ryan McBride |
09/29/09 |
Boston
|
|
Medical Device Pioneer David Auth Seethes Over $40 Billion Industry Tax Idea, FDA Delays
|
Luke Timmerman |
09/15/09 |
Seattle
|
|
What’s an Entrepreneur To Do? Amidst Mixed Signals for Economic Recovery, Four Experts Share Strategies for Startup and Business Success
|
Robert Buderi |
07/23/09 |
Boston
|
|
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today
|
Luke Timmerman |
06/03/09 |
Boston
|
|
CoAptus Medical, With $3M in Hand, Seeks to Seal Up Heart Defects that Lead to Stroke
|
Luke Timmerman |
05/19/09 |
Seattle
|
|
The Recovery Starts Here—Xconomy Announces XSITE 2009 Event to Celebrate Innovation in New England
|
Robert Buderi |
05/07/09 |
Boston
|
|
Reva Medical Regaining Ground in Development of Next-Generation Stent
|
Denise Gellene |
05/05/09 |
San Diego
|
|
GI Dynamics Adds Device to Gut Liner to Increase Weight Loss
|
Ryan McBride |
04/29/09 |
Boston
|
|
Biogen and Icahn Duel Again, Marinus Gets $20M, Vigilance Urged on Patent Reform, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/15/09 |
Boston
|
|
From Movie Sets to Operating Rooms, Chamberlain Group Turns Special Effects Biz into Healthcare Winner
|
Ryan McBride |
04/13/09 |
Boston
|
|
Mass Medical Angels Forms to Invest in Life Sciences Startups—And Get the Ball Rolling for VCs
|
Ryan McBride |
04/03/09 |
Boston
|
|
Pathway Medical Raises $40M for Device to Clear Out Blocked Leg Arteries
|
Luke Timmerman |
03/26/09 |
Seattle
|
|
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/25/09 |
Boston
|
|
Boston Scientific: $50M Settlement over Stents
|
Wade Roush |
03/20/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
HeartWare Takes $282M Buyout
|
Ryan McBride |
02/13/09 |
Boston
|
|
Pathway Medical Tool Shows Early Signs of Emerging as “Real Winner”
|
Luke Timmerman |
02/02/09 |
Seattle
|
|
Boston Scientific and Rival Settle Suits
|
Ryan McBride |
01/27/09 |
Boston
|
|
Cardiac Dimensions, Fixer of Leaky Hearts, Edges Toward European Market and Pivotal U.S. Test
|
Luke Timmerman |
01/26/09 |
Seattle
|
|
Pathway’s New CEO Carves Out Market in the Legs & Beyond
|
Luke Timmerman |
01/13/09 |
Seattle
|
|
Massachusetts’ Life Sciences Czar Talks Strategy Amid Squeeze on State Spending and Stingy Financial Market
|
Ryan McBride |
01/13/09 |
Boston
|
|
Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
01/07/09 |
Boston
|
|
BSX Buys Irish Stent Firm
|
Ryan McBride |
01/06/09 |
Boston
|
|
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/17/08 |
Boston
|
|
FDA Approves BSX Renal Stent
|
Ryan McBride |
12/15/08 |
Boston
|
|
Alkermes Regains Vivitrol Rights, Biogen Idec Heads for the Burbs, A Peek at Partners Innovation Fund’s Portfolio, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/03/08 |
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
